⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SKYE News
Skye Bioscience, Inc. Common Stock
Skye Bioscience Reports Third Quarter 2025 Financial Results and Business Update
globenewswire.com
SKYE
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
globenewswire.com
SKYE
Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025
globenewswire.com
SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
accessnewswire.com
SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
accessnewswire.com
SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
prnewswire.com
SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
prnewswire.com
SKYE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
prnewswire.com
SKYE
Skye Bioscience Reports Topline CBeyond™ Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial
globenewswire.com
SKYE